( NASDAQ-NMS:SVA )

News from Sinovac Biotech Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

15 Nov, 2016, 06:00 ET Sinovac to Host Conference Call to Report Third Quarter 2016 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


07 Nov, 2016, 06:00 ET Sinovac Announces Results of 2016 Annual General Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2016...


19 Oct, 2016, 06:00 ET Sinovac Product Pipeline News

BEIJING, Oct. 19, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today...


26 Oct, 2015, 06:00 ET Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac...


14 Sep, 2015, 06:00 ET Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the...


10 Sep, 2015, 06:00 ET Sinovac to Participate in Morgan Stanley Global Healthcare Conference

BEIJING, Sept. 10, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today...


18 Mar, 2015, 06:00 ET Sinovac to Participate in China Medical and Healthcare Investment Conference

Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in...


17 Mar, 2015, 06:00 ET Sinovac Provides Updates on Pipeline Vaccines

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today provided updates on the Company's pipeline...


14 Nov, 2014, 16:30 ET Sinovac Reports Unaudited Third Quarter Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for...


05 Nov, 2014, 04:00 ET Sinovac to Host Conference Call to Report Third Quarter 2014 Unaudited Financial Results

BEIJING, Nov. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today...


21 Oct, 2014, 06:06 ET Sinovac to Participate in Jefferies 4th Annual Asia Summit

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management...


05 Sep, 2014, 06:00 ET Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis...


02 Sep, 2014, 06:00 ET Sinovac to Participate in Upcoming Investor Conferences

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management...


27 Aug, 2014, 06:00 ET Sinovac Announces Results of 2014 Annual General Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014...


14 Aug, 2014, 12:49 ET Sinovac Reports Unaudited Second Quarter Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and...


25 Jul, 2014, 05:00 ET Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


23 Jul, 2014, 06:00 ET Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...


21 Jul, 2014, 06:00 ET Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...


14 Jul, 2014, 06:00 ET Sinovac Schedules 2014 Annual Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2014 Annual...


25 Jun, 2014, 06:00 ET Sinovac Announces Favorable Reduction in Value Added Tax Rate

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the value added tax (or "VAT")...


21 May, 2014, 18:00 ET Sinovac Reports Unaudited First Quarter 2014 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter...


12 May, 2014, 06:00 ET Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


28 Apr, 2014, 06:09 ET Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development,...


19 Mar, 2014, 18:00 ET Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and...


29 Jan, 2014, 07:07 ET Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical...